Healthcare -
Biotechnology - NASDAQ - US
$ 6.385
3.15 %
$ 286 M
Market Cap
-11.82
P/E
YMAB - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative YMAB - Y-mAbs Therapeutics, Inc.
44.9 M
LAST VALUE
-9.34%
2 YEAR CAGR
38.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR